Notebook
September 30th, 2007 by Richard Brassaw

Scientists knew it was happening, but it remained a mystery as to what causes cell death in frontotemporal dementia (FTD). A recent study using cell cultures shows the pathological pathway that leads to the cell death as reported in the Journal of Neuroscience.
FTD affects the frontal and temporal lobes of the brain. It causes changes in personality, [...]

September 29th, 2007 by Richard Brassaw

Pharmaceutical companies often distribute news releases about new drugs in clinical trials. Usually, there is a reference to a phase ranging from 1 to 4. Ever wonder what Phase II or Phase III clinical trials actually mean? This is a synopsis of the different types of clinical trials provided by the National Institutes of Health.
Phase I:
Study involves a [...]

September 28th, 2007 by Richard Brassaw

Fibromyalgia patients often suffer from chronic pain, but for some reason they find commonly prescribed pain medications are not very effective. Researchers at the University of Michigan Health System believe they may know the reason.
Pain killers, like Darvocet,Vicodin, and Oxycontin, work by binding to opioid receptors in the brain and spinal cord. The study of [...]

September 27th, 2007 by Richard Brassaw

Long-Term Disability (LTD) seems like a good idea. After all, 1 out of 3 U.S. workers will require some form of supplemental disability income during their lifetime. Since most workers can only survive 3 months out of work, it makes LTD insurance sound better all the time. At least that is what the insurance companies want [...]

September 27th, 2007 by Richard Brassaw

This new feature was inspired by the documentary film, “bad faith.” Take a moment and share your experience being denied a disability claim.
Click here to —> Share Your Bad Faith Story

September 26th, 2007 by Richard Brassaw

California, in an effort to assist its disabled residents to improve their situation, created the California Health Incentives Improvement Project (CHIIP). Its goal is to improve self-sufficiency and employment of the disabled. In particular, it wants to improve health care and eliminate personal assistance barriers.
In the not too distant past disabled people who wanted to [...]

September 26th, 2007 by Richard Brassaw

Heanne Hambleton lives in England and has found what so many other Fibromyalgia patients have experienced world wide–that it is difficult for friends, family, and neighbors to understand and appreciate the pain and suffering. It is sometimes difficult to comprehend how someone can look so normal, but be in constant pain.
In a recent post, Hambleton [...]

September 25th, 2007 by Richard Brassaw

When it comes to memory processing, scientists have been able to use functional magnetic resonance imaging (fMRI) to observe changes in the brain. Previously, researchers observed the medial temporal lobe (MTL) portion of the brain as it activated during memory task.
Researchers at Duke University Medical Center set out to identify brain regions related to memory and to [...]

September 24th, 2007 by Richard Brassaw

Researchers at The Scripps Research Institute found tetrahydrocannabinol (THC), marijuana’s active ingredient, inhibits the formation of amyloid plaque, which is thought to be involved with the development of Alzheimer’s disease.
Surprisingly, marijuana’s active ingredient, THC, was found to work better at inhibiting amyloid plaque than several of the drugs approved by the Federal Drug Administration (FDA) [...]

September 23rd, 2007 by Richard Brassaw

Researchers at Baycrest, center focused on aging, recently announced the results of a head-to-head comparison of an SSRI (selective serotonin reuptake inhibitor) with one of the more commonly prescribed second generation antipsychotics used in the treatment of older, non-depressed dementia patients.
The results were surprising. They found evidence that an antidepressant (citalopram) may perform as well as frequently prescribed [...]